Both in Biotechnology
Biogen vs Revolution Medicines
Over the past year BIIB returned +63.9% and RVMD returned +343.8%; their daily moves had a correlation of 0.14.
BIIB +63.9% RVMD +343.8%Growth of $1, one year, split-adjusted
| Metric | BIIB | RVMD |
|---|---|---|
| Price | $227.07 | $204.48 |
| Market cap | $33.55B | $43.83B |
| Today | −0.71% | +1.36% |
| 1 month | +3.9% | −1.6% |
| 6 months | +21.1% | +120.6% |
| Year to date | +29.0% | +156.7% |
| 1 year | +65.3% | +365.6% |
| Revenue growth (YoY) | +3.4% | — |
| Gross margin | 71.6% | — |
| Net margin | 3.6% | — |
| P/E (TTM) | 40.2× | — |
| Price / sales | 3.3× | — |
| Net cash | -$6.81B | $3.45B |
| Dividend yield | — | — |
| Volatility (60d) | 35.2% | 36.5% |
| Short % of float | 3.9% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).